Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Davide Capodanno , Sneha Shah Jain Added: 4 months ago
Presented at the European Society of Cardiology (ESC) Congress 2025, Prof Carolyn Lam (Singapore, UK), Prof Davide Capodanno (Catania, IT), Dr Sneha Shah Jain (Stanford, US) and Prof Jeffrey Weitz (Hamilton, CA) examine the prevalence and challenges of stroke prevention in atrial fibrillation (AF) and after acute coronary syndrome (ACS). The faculty review current treatment guidelines, explore… View more
Author(s): Carolyn Lam , Jeffrey Weitz Added: 4 months ago
Hear from Prof Carolyn Lam and Prof Jeffrey Weitz as they share key take-home messages from ESC 2025.Filmed onsite, this peer-to-peer discussion distils the latest updates in thrombosis management for acute coronary syndrome (ACS), secondary stroke prevention (SSP) and atrial fibrillation (AF).Register for the upcoming Q&A webinar, taking place on 6 October (14:00 EDT / 20:00 CEST), to put your… View more
Author(s): Carolyn Lam , Jeffrey Weitz , Sneha Shah Jain Start date: Oct 06, 2025
Following the ESC 2025 symposium 'Revolutionising Thrombosis Treatment in ACS, SSP and AF – Bridging the Gaps With Next Generation Anticoagulation Strategies', this live Q&A webinar offers an exclusive chance to continue the conversation.Join Prof Carolyn Lam (Singapore, UK), Prof Jeffrey Weitz (Hamilton, CA) and Dr Sneha Shah Jain (Stanford, US) as they address your questions on stroke… View more
Author(s): Christian Sohns , Added: 2 years ago
ESC 2023 — We are joined onsite by Prof Christian Sohns and Prof Philipp Sommer (Heart and Diabetes Centre, Bad Oyenhausen, DE) to discuss the findings from the CASTLE-HTx trial (NCT04649801). CASTLE-HTx (Heart and Diabetes Center North-Rhine Westfalia) aimed to determine if atrial fibrillation ablation has beneficial effects on mortality in patients with end-stage heart failure, who are… View more
Job title: President
Antonio Raviele is President and Contact of the Venice Arrhythmias Scientific Secretariat - the renowned congress of arrhythmology he created in 1989. Between 2008 and 2011 he was Director of the Cardiovascular Department of the Angelo dell'Angelo Hospital. Following his retirement, he practices cardiologist and arrhythmologist at his private practice in Mestre. He was the author of the first… View more
Job title: Consultant and Professor of Cardiology
Personal History Professor Ross Jacob Hunter was born in 1977 in the UK. He is a Consultant Cardiologist specialising in arrhythmia management and the clinical lead for AF services at The Barts Heart Centre.3 Academic History Prof Hunter earned his BSc in Cardiovascular Medicine from Imperial College London in 1998. In 2001, he was awarded an MBBS with a distinction from Guy’s Kings … View more
Prof Carlos Morillo is a cardiac electrophysiologist, currently serving in the Chief Division of Cardiology at theLibin Cardiovascular Institute, University of Calgary, Calgary, Alberta, Canada. Prof Morillo has extensively researched Chagas disease since 1990, and was involved in the initial studies related to autonomic control in the different stages of the disease and the use of beta… View more
Job title: Director, Atrial Fibrillation Clinic, Electrodiagnostics, and Cardiac Electrophysiology
Dr Jason Andrade is a Cardiac Electrophysiologist at Vancouver General Hospital in Canada, with joint appointment at St Paul’s Hospital and the Montreal Heart Institute. He is an Associate Professor of Medicine at the University of British Columbia (UBC), and an Adjunct Professor at the Université de Montréal. DrAndrade is the Director of the Electrophysiology Program at VGH, as well as Head of… View more
Added: 1 year ago Source:  ESC Congress
The European Society of Cardiology has revealed 12 Hot-Line trial sessions to be presented at the end of August.ESC Congress 2024 will be held from the 30thAugust to the 2nd September at the ExCel Center in London. View the full programme here.Don't miss our video collection covering late-breaking data from ESC Congress 2024, including a preview of the most anticipated trials in View from the… View more
Dr David Conen is a cardiologist, scientist and principal investigator at the Population Health Institute at McMaster University in Hamilton, Canada. Dr Conen is Principal Investigator of two major international trials studying the treatment and prevention of atrial fibrillation – the COP-AF and ASPIRE-AF Trials. View more